Chitosan oligosaccharide improves the therapeutic efficacy of sitagliptin for the therapy of Chinese elderly patients with type 2 diabetes mellitus

References

• GildenJLGuptaANon-ICU hospital care of diabetes mellitus in the elderly populationCurr Diab Rep20151552625772641
   PubMed Web of Science ®Google Scholar
• WildSRoglicGGreenASicreeRKingHGlobal prevalence of diabetes: estimates for the year 2000 and projections for 2030Diabetes Care20042751047105315111519
   PubMed Web of Science ®Google Scholar
• BramlagePGittAKBinzCKreklerMDeegETschopeDOral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemiaCardiovasc Diabetol20121112223039216
   PubMed Web of Science ®Google Scholar
• BordierLBuysschaertMBauduceauBPredicting factors of hypoglycaemia in elderly type 2 diabetes patients: contributions of the GERODIAB studyDiabetes Metab201541430130325845279
   PubMed Web of Science ®Google Scholar
• SureshPSSrinivasNRMullangiRA concise review of the bioanalytical methods for the quantitation of sitagliptin, an important dipeptidyl peptidase-4 (DPP4) inhibitor, utilized for the characterization of the drugBiomed Chromatogr201630574977126873580
   PubMed Web of Science ®Google Scholar
• GoldshteinIKarasikAMelzer-CohenCUrinary albumin excretion with sitagliptin compared to sulfonylurea as add on to metformin in type 2 diabetes patients with albuminuria: a real-world evidence studyJ Diabetes Complications20163071354135927320183
   PubMed Web of Science ®Google Scholar
• AliSMKhalifaHMostafaDKEl SharkawyASuppression of connective tissue growth factor mediates the renoprotective effect of sitagliptin rather than pioglitazone in type 2 diabetes mellitusLife Sci201615318018727049870
   PubMed Web of Science ®Google Scholar
• ShankarRRXuLGolmGTA comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitusInt J Clin Pract201569662663125652751
   PubMed Web of Science ®Google Scholar
• BaraniukJNJamiesonMJRhinorrhea, cough and fatigue in patients taking sitagliptinAllergy Asthma Clin Immunol201061820462426
   PubMedGoogle Scholar
• Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancerPrescrire Int20091810111519637427
   PubMedGoogle Scholar
• NgoD-HVoT-SNgoD-NBiological effects of chitosan and its derivativesFood Hydrocoll201551200216
   Web of Science ®Google Scholar
• LiXShiXJinYDingFDuYControllable antioxidative xylan–chitosan Maillard reaction products used for lipid food storageCarbohydr Polym201391142843323044153
   PubMed Web of Science ®Google Scholar
• TeixeiraGQLeite PereiraCCastroFAnti-inflammatory chitosan/poly-γ-glutamic acid nanoparticles control inflammation while remodeling extracellular matrix in degenerated intervertebral discActa Biomater20164216817927321188
   PubMed Web of Science ®Google Scholar
• KarahalilogluZKilicayEDenkbasEBAntibacterial chitosan/silk sericin 3D porous scaffolds as a wound dressing materialArtif Cells Nanomed Biotechnol Epub201679
   Web of Science ®Google Scholar
• KerchGThe potential of chitosan and its derivatives in prevention and treatment of age-related diseasesMar Drugs20151342158218225871293
   PubMed Web of Science ®Google Scholar
• CobradoLSilva-DiasAAzevedoMMPina-VazCRodriguesAGIn vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infectionsJ Antimicrob Chemother201368112613022991425
   PubMed Web of Science ®Google Scholar
• KimJGJoSHHaKSEffect of long-term supplementation of low molecular weight chitosan oligosaccharide (GO2KA1) on fasting blood glucose and HbA1c in db/db mice model and elucidation of mechanism of actionBMC Complement Altern Med20141427225074485
   PubMed Web of Science ®Google Scholar
• KimHJAhnHYKwakJHThe effects of chitosan oligosaccharide (GO2KA1) supplementation on glucose control in subjects with prediabetesFood Funct20145102662266925222285
   PubMed Web of Science ®Google Scholar
• YuSYKwonYILeeCApostolidisEKimYCAntidiabetic effect of chitosan oligosaccharide (GO2KA1) is mediated via inhibition of intestinal alpha-glucosidase and glucose transporters and PPARBioFactors2017431909927388525
   PubMed Web of Science ®Google Scholar
• SkwarczynskiMGhaffarAKGiddamAKBatzloffMGoodMTothIHighly immunogenic trimethyl chitosan-based delivery system for intranasal lipopeptide vaccines against group A streptococcusCurr Drug Deliv Epub2016721
   Web of Science ®Google Scholar
• YousefMPichyangkuraRSoodvilaiSChatsudthipongVMuanprasatCChitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of actionPharmacol Res2012661667922475725
   PubMed Web of Science ®Google Scholar
• DennhartNFukamizoTBrzezinskiRLacombe-HarveyMELetzelTOligosaccharide hydrolysis by chitosanase enzymes monitored by real-time electrospray ionization-mass spectrometryJ Biotechnol20081343–425326018359118
   PubMed Web of Science ®Google Scholar
• General Assembly of the World Medical AssociationWorld Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjectsJ Am Coll Dent2014813141825951678
   PubMedGoogle Scholar
• EngelgauMMThompsonTJHermanWHComparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisitedDiabetes Care19972057857919135943
   PubMed Web of Science ®Google Scholar
• Arjona FerreiraJCCorryDMogensenCEEfficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trialAm J Kidney Dis201361457958723352379
   PubMed Web of Science ®Google Scholar
• SakamotoYOyamaJIkedaHEffects of sitagliptin beyond glycemic control: focus on quality of lifeCardiovasc Diabetol2013123523432786
   PubMed Web of Science ®Google Scholar
• WangTGouZWangFMaMZhaiSDComparison of GLP-1 analogues versus sitagliptin in the management of type 2 diabetes: systematic review and meta-analysis of head-to-head studiesPLoS One201498e10379825089625
   PubMed Web of Science ®Google Scholar
• ZhaoQHongDZhengDXiaoYWuBRisk of diarrhea in patients with type 2 diabetes mellitus treated with sitagliptin: a meta-analysis of 30 randomized clinical trialsDrug Des Devel Ther2014822832294
   PubMed Web of Science ®Google Scholar
• FreemanDJNorrieJCaslakeMJC-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention StudyDiabetes20025151596160011978661
   PubMed Web of Science ®Google Scholar
• XuHUysalKTBechererJDArnerPHotamisligilGSAltered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesityDiabetes20025161876188312031976
   PubMed Web of Science ®Google Scholar
• YamamotoHMaedaKUjiYAssociation between reduction of plasma adiponectin levels and risk of bacterial infection after gastric cancer surgeryPLoS One201383e5612923520452
   PubMed Web of Science ®Google Scholar
• ShehzadAIqbalWShehzadOLeeYSAdiponectin: regulation of its production and its role in human diseasesHormones201211182022450341
   PubMedGoogle Scholar
• MohammadzadehGZarghamiNHypoadiponectinemia in obese subjects with type II diabetes: a close association with central obesity indicesJ Res Med Sci201116671372322091299
   PubMed Web of Science ®Google Scholar
• SantilliFLianiRDi FulvioPIncreased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitusThromb Haemost201611661089109927709225
   PubMed Web of Science ®Google Scholar
• KorovkinVSРеакция С-реактивного белка у пациентов с туберкулезом и сахарным диабетом [The C-reactive protein reaction in patients with tuberculosis and diabetes mellitus]Probl Tuberk19684679091 Russian
   PubMedGoogle Scholar
• ZiamajidiNNasiriAAbbasalipourkabirRSadeghi MohebSEffects of garlic extract on TNF-alpha expression and oxidative stress status in the kidneys of rats with STZ + nicotinamide-induced diabetesPharm Biol201755152653127937047
   PubMed Web of Science ®Google Scholar
• PawlikATelerJMaciejewskaASawczukMSafranowKDziedziejkoVAdiponectin and leptin gene polymorphisms in women with gestational diabetes mellitusJ Assist Reprod Genet201734451151628050671
   PubMed Web of Science ®Google Scholar
• CerielloAEspositoKTestaRBonfigliARMarraMGiuglianoDThe possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an “endothelial resistance” to glucagon-like peptide 1 in diabetesDiabetes Care201134369770221273492
   PubMed Web of Science ®Google Scholar